Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.92 USD | +0.22% | +0.79% | +24.46% |
12/04 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
08/04 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Business Summary
- provision of development services and clinical supply services (55.4%);
- subcontracted manufacturing services (44.6%).
Net sales are distributed geographically as follows: the United States (63.2%), Europe (28.7%) and other (8.1%).
Number of employees: 17,800
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharma and Consumer Health
53.6
%
| - | - | 2,287 | 53.6 % | - |
Biologics
46.4
%
| 2,549 | 52.8 % | 1,978 | 46.4 % | -22.40% |
Inter-Segment Revenue Elimination
0.0
%
| -17 | -0.4 % | -2 | 0.0 % | -88.24% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
64.9
%
| 3,110 | 64.4 % | 2,768 | 64.9 % | -11.00% |
Europe
29.5
%
| 1,506 | 31.2 % | 1,257 | 29.5 % | -16.53% |
Other
8.3
%
| 327 | 6.8 % | 355 | 8.3 % | +8.56% |
Elimination of Revenue Attributable to Multiple Locations
-2.7
%
| -115 | -2.4 % | -117 | -2.7 % | +1.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 01/10/01 | |
Matti Masanovich
DFI | Director of Finance/CFO | 52 | 05/23/05 |
Lim Chin Wei
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Chief Tech/Sci/R&D Officer | - | 19/19/19 | |
Joseph Ferraro
CMP | Compliance Officer | 47 | 13/23/13 |
Charles Lickfold
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Paul Surdez
IRC | Investor Relations Contact | - | 07/20/07 |
Ricardo Pravda
PRN | Corporate Officer/Principal | 53 | 01/05/01 |
Michael Hatzfeld
AUD | Comptroller/Controller/Auditor | 51 | 16/01 |
Corporate Officer/Principal | 53 | 19/22/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
BRD | Director/Board Member | 79 | 01/14/01 |
John Greisch
CHM | Chairman | 68 | 16/18/16 |
J. Carroll
BRD | Director/Board Member | 74 | 28/15/28 |
Jack Stahl
BRD | Director/Board Member | 71 | 30/14/30 |
Donald Morel
BRD | Director/Board Member | 67 | 01/15/01 |
Frank D'Amelio
BRD | Director/Board Member | 66 | 29/23/29 |
Gregory Lucier
BRD | Director/Board Member | 60 | 01/15/01 |
Michael Barber
BRD | Director/Board Member | 64 | 28/21/28 |
Chief Executive Officer | 52 | 01/10/01 | |
Steven Barg
BRD | Director/Board Member | 62 | 29/23/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 180,974,218 | 175,722,027 ( 97.10 %) | 0 | 97.10 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.46% | 10.12B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CTLT Stock
- Company Catalent, Inc.